| abstract |
The present invention provides novel substituted pyrimidinyl-amines that are useful as inhibitors of protein kinases, especially c-Jun N-terminal kinases (JNK) and pharmaceutical compositions thereof and methods of using the same for treating conditions responsive to the inhibition of the JNK pathway. More particularly, the present invention relates to a compound or pharmaceutically acceptable salt thereof of formula lb: (see formula Ib) |